Bearish flow noted in Apellis Pharmaceuticals with 4,163 puts trading, or 1.5x expected. Most active are Mar-23 35 puts and Mar-23 25 puts, with total volume in those strikes near 2,900 contracts. The Put/Call Ratio is 5.87, while ATM IV is up nearly 15 points on the day. Earnings are expected on February 27th.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on APLS:
- Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Citi opens ‘positive 30-day Catalyst Watch’ on Apellis into FDA decision
- JPMorgan sees Apellis rally with FDA action date fast approaching
- Apellis expects 2022 Empaveli revenue of $65M
- Sell these stocks now, proven algorithm says